275 related articles for article (PubMed ID: 14619957)
1. Malonyl-CoA and AMP-activated protein kinase: an expanding partnership.
Saha AK; Ruderman NB
Mol Cell Biochem; 2003 Nov; 253(1-2):65-70. PubMed ID: 14619957
[TBL] [Abstract][Full Text] [Related]
2. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise.
Park H; Kaushik VK; Constant S; Prentki M; Przybytkowski E; Ruderman NB; Saha AK
J Biol Chem; 2002 Sep; 277(36):32571-7. PubMed ID: 12065578
[TBL] [Abstract][Full Text] [Related]
3. Effect of phosphorylation by AMP-activated protein kinase on palmitoyl-CoA inhibition of skeletal muscle acetyl-CoA carboxylase.
Rubink DS; Winder WW
J Appl Physiol (1985); 2005 Apr; 98(4):1221-7. PubMed ID: 15579580
[TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
[TBL] [Abstract][Full Text] [Related]
5. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line.
Habinowski SA; Hirshman M; Sakamoto K; Kemp BE; Gould SJ; Goodyear LJ; Witters LA
Arch Biochem Biophys; 2001 Dec; 396(1):71-9. PubMed ID: 11716464
[TBL] [Abstract][Full Text] [Related]
6. Malonyl CoA as a metabolic switch and a regulator of insulin sensitivity.
Ruderman NB; Saha AK; Vavvas D; Kurowski T; Laybutt DR; Schmitz-Peiffer C; Biden T; Kraegen EW
Adv Exp Med Biol; 1998; 441():263-70. PubMed ID: 9781332
[TBL] [Abstract][Full Text] [Related]
7. Malonyl-CoA, fuel sensing, and insulin resistance.
Ruderman NB; Saha AK; Vavvas D; Witters LA
Am J Physiol; 1999 Jan; 276(1):E1-E18. PubMed ID: 9886945
[TBL] [Abstract][Full Text] [Related]
8. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
Folmes CD; Lopaschuk GD
Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
[TBL] [Abstract][Full Text] [Related]
9. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
10. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
Tomas E; Tsao TS; Saha AK; Murrey HE; Zhang Cc Cc; Itani SI; Lodish HF; Ruderman NB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16309-13. PubMed ID: 12456889
[TBL] [Abstract][Full Text] [Related]
11. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
12. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise.
Winder WW; Hardie DG
Am J Physiol; 1996 Feb; 270(2 Pt 1):E299-304. PubMed ID: 8779952
[TBL] [Abstract][Full Text] [Related]
14. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
15. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta -D-ribofuranoside.
Saha AK; Schwarsin AJ; Roduit R; Masse F; Kaushik V; Tornheim K; Prentki M; Ruderman NB
J Biol Chem; 2000 Aug; 275(32):24279-83. PubMed ID: 10854420
[TBL] [Abstract][Full Text] [Related]
16. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
[TBL] [Abstract][Full Text] [Related]
17. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR.
Kaushik VK; Young ME; Dean DJ; Kurowski TG; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E335-40. PubMed ID: 11440910
[TBL] [Abstract][Full Text] [Related]
18. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart.
Sakamoto J; Barr RL; Kavanagh KM; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1196-204. PubMed ID: 10749714
[TBL] [Abstract][Full Text] [Related]
19. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
Lane MD; Wolfgang M; Cha SH; Dai Y
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
[TBL] [Abstract][Full Text] [Related]
20. Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase.
Rasmussen BB; Winder WW
J Appl Physiol (1985); 1997 Oct; 83(4):1104-9. PubMed ID: 9338417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
